J. Hradec et al., ALTERATIONS OF PHOSPHATIDYLCHOLINE CONCENTRATIONS IN THE SERUM OF PATIENTS WITH MAMMARY-CANCER, Oncology Reports, 5(2), 1998, pp. 513-516
As determined by reversed-phase liquid-solid extraction, concentration
of total phosphatidylcholines in the serum of 53 patients with mammar
y cancer was significantly (P<0.003) increased to 2.24+/-0.59 mg/ml wh
en compared with the normal value of 1.86+/-0.36 mg/ml. In 31 fraction
s of their individual molecular species separated by high-performance
liquid chromatography there was a shift to compounds composed of longe
r fatty acids that were significantly more abundant than in normal ser
um. The concentration of fractions containing stearic, oleic, linoleic
, eicosatrienoic, arachidonic and docosahexaenoic acid as well as trac
es of C17 acids was 2-5 fold enhanced. On the other hand, molecular sp
ecies containing palmitic acid combined with palmitoleic, oleic linole
ic, arachidonic and further polyunsaturated fatty acids are considerab
ly decreased in cancer serum. All these atypical phosphatidylcholines
are apparently specific products of tumor cells and are released into
the blood stream. The possibility of using these alterations of phosph
olipid metabolism for the follow-up of cancer patients is further inve
stigated.